For: | Pappachan JM, Varughese GI, Sriraman R, Arunagirinathan G. Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management. World J Diabetes 2013; 4(5): 177-189 [PMID: 24147202 DOI: 10.4239/wjd.v4.i5.177] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v4/i5/177.htm |
Number | Citing Articles |
1 |
Raphael M. Singh, Tahreem Waqar, Frank C. Howarth, Ernest Adeghate, Keshore Bidasee, Jaipaul Singh. Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart. Heart Failure Reviews 2018; 23(1): 37 doi: 10.1007/s10741-017-9663-y
|
2 |
Lin Sun, Ming Yu, Tong Zhou, Siwen Zhang, Guangyu He, Guixia Wang, Xiaokun Gang. Current advances in the study of diabetic cardiomyopathy: From clinicopathological features to molecular therapeutics (Review). Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10473
|
3 |
Heyangzi Li, Shi Bai, Xi Cao, Lijuan Wu, Xiaoming Zhang. Differential Expression Profiles of Transfer RNA-Derived Small RNAs and Their Potential Roles in Diabetic Cardiomyopathy. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4162445
|
4 |
Mona F El-Azab, Ahmed E Wakiel, Yossef K Nafea, Mahmoud E Youssef. Role of cannabinoids and the endocannabinoid system in modulation of diabetic cardiomyopathy. World Journal of Diabetes 2022; 13(5): 387-407 doi: 10.4239/wjd.v13.i5.387
|
5 |
Hooi Hooi Ng, Chen Huei Leo, Laura J. Parry, Rebecca H. Ritchie. Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00501
|
6 |
Isabel Álvarez, Luis Hernández, Héctor García, Vicente Villamandos, María Gracia López, Jorge Palazuelos Molinero, Diego Martín Raymondi. Troponina T ultrasensible en pacientes asintomáticos de muy alto riesgo cardiovascular. Registro TUSARC. Revista Española de Cardiología 2017; 70(4): 261 doi: 10.1016/j.recesp.2016.08.018
|
7 |
John M. Clements, Mariana Rosca, Carla Cavallin, Shelby Falkenhagen, Thomas Ittoop, Christina K. Jung, Megan Mazzella, Joseph A. Reed, Megan Schluentz, Caleb VanDyke. Type 2 Diabetes and Chronic Conditions Disparities in Medicare Beneficiaries in the State of Michigan. The American Journal of the Medical Sciences 2020; 359(4): 218 doi: 10.1016/j.amjms.2020.01.013
|
8 |
Chen Xuan, Yan Luo, Yu Xiong, Yudi Zhang, Chunhe Tao, Wenfu Cao. Multitarget mechanism of Yiqi Jiedu Huayu decoction on diabetic cardiomyopathy based on network pharmacology. European Journal of Integrative Medicine 2021; 47: 101388 doi: 10.1016/j.eujim.2021.101388
|
9 |
A. Uryash, A. Mijares, V. Flores, J. A. Adams, J. R. Lopez. Effects of Naringin on Cardiomyocytes From a Rodent Model of Type 2 Diabetes. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.719268
|
10 |
Joel A. Strom. Diabetic Heart Disease: Insights from Cardiac Mechanics. Journal of the American Society of Echocardiography 2014; 27(5): 489 doi: 10.1016/j.echo.2014.03.008
|
11 |
Igor V. Mukhin, Kirill S. Zubritsky. Dynamics of changes in heart rate, ST segment and T-wave on patients with ventricular rhythm disturbances on the background of type 2 diabetes mellitus according to the results of 24-hour cardiac monitoring. Journal of Volgograd State Medical University 2024; 21(3): 81 doi: 10.19163/1994-9480-2024-21-3-81-86
|
12 |
Nihal Ozturk, Serkan Uslu, Semir Ozdemir. Diabetes-induced changes in cardiac voltage-gated ion channels. World Journal of Diabetes 2021; 12(1): 1-18 doi: 10.4239/wjd.v12.i1.1
|
13 |
К.Р. Товмасян, Ф.Х. Оракова. THE RELEVANCE OF DIASTOLIC RESERVE OF THE LEFT VENTRICLE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (literature review). Успехи геронтологии 2024; 37(3): 251 doi: 10.34922/AE.2024.37.3.011
|
14 |
Saumik Biswas, Subrata Chakrabarti. Increased Extracellular Matrix Protein Production in Chronic Diabetic Complications: Implications of Non-Coding RNAs. Non-Coding RNA 2019; 5(1): 30 doi: 10.3390/ncrna5010030
|
15 |
Yuhong Fan, Jingjing Liu, Lei Jin, Zhonghe Liu, Lixiang Han, Yue Wang, Yangyang Zhang, Peiming Shen, Zhi Li. Impacts of metabolic disorders on short- and long-term mortality after coronary artery surgery in the elderly. BMC Cardiovascular Disorders 2022; 22(1) doi: 10.1186/s12872-022-02954-6
|
16 |
Ahsan Riaz Khan, Mohammed A.H Alnoud, Hamid Ali, Ijaz Ali, Saleem Ahmad, Syed Shams ul Hassan, Abdul Lateef Shaikh, Talib Hussain, Munir Ullah Khan, Safir Ullah Khan, Muhammad Shehzad Khan, Shahid Ullah Khan. Beyond the beat: A pioneering investigation into exercise modalities for alleviating diabetic cardiomyopathy and enhancing cardiac health. Current Problems in Cardiology 2024; 49(2): 102222 doi: 10.1016/j.cpcardiol.2023.102222
|
17 |
Preeti Sharma, Younis Ahmad Hajam, Rajesh Kumar, Seema Rai. Complementary and alternative medicine for the treatment of diabetes and associated complications: A review on therapeutic role of polyphenols. Phytomedicine Plus 2022; 2(1): 100188 doi: 10.1016/j.phyplu.2021.100188
|
18 |
Mariann Bombicz, Daniel Priksz, Rudolf Gesztelyi, Rita Kiss, Nora Hollos, Balazs Varga, Jozsef Nemeth, Attila Toth, Zoltan Papp, Zoltan Szilvassy, Bela Juhasz. The Drug Candidate BGP-15 Delays the Onset of Diastolic Dysfunction in the Goto-Kakizaki Rat Model of Diabetic Cardiomyopathy. Molecules 2019; 24(3): 586 doi: 10.3390/molecules24030586
|
19 |
Lin Wang, Yin Cai, Liguo Jian, Chi Wai Cheung, Liangqing Zhang, Zhengyuan Xia. Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy. Cardiovascular Diabetology 2021; 20(1) doi: 10.1186/s12933-020-01188-0
|
20 |
Yue Gao, Yan Ren, Ying-kun Guo, Xi Liu, Lin-jun Xie, Li Jiang, Meng-ting Shen, Ming-yan Deng, Zhi-gang Yang. Metabolic syndrome and myocardium steatosis in subclinical type 2 diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Cardiovascular Diabetology 2020; 19(1) doi: 10.1186/s12933-020-01044-1
|
21 |
Saviana A. Barbati, Claudia Colussi, Lorenza Bacci, Aurora Aiello, Agnese Re, Egidio Stigliano, Andrea M. Isidori, Claudio Grassi, Alfredo Pontecorvi, Antonella Farsetti, Carlo Gaetano, Simona Nanni. Transcription Factor CREM Mediates High Glucose Response in Cardiomyocytes and in a Male Mouse Model of Prolonged Hyperglycemia. Endocrinology 2017; 158(7): 2391 doi: 10.1210/en.2016-1960
|
22 |
Ke Song, Dianyuan Liang, Dingqi Xiao, Aijia Kang, Yixing Ren. Role of bariatric surgery in improving diabetic cardiomyopathy: Molecular mechanisms and therapeutic perspectives (Review). Molecular Medicine Reports 2024; 30(5) doi: 10.3892/mmr.2024.13323
|
23 |
Thomas H. Marwick, Rebecca Ritchie, Jonathan E. Shaw, David Kaye. Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy. Journal of the American College of Cardiology 2018; 71(3): 339 doi: 10.1016/j.jacc.2017.11.019
|
24 |
Goltaj Bayrami, Pouran Karimi, Fariba Agha-Hosseini, Saeid Feyzizadeh, Reza Badalzadeh. Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin. Journal of Cardiovascular Pharmacology and Therapeutics 2018; 23(2): 174 doi: 10.1177/1074248417729881
|
25 |
Kanika Manral, Anita Singh, Yuvraj Singh. NANOTECHNOLOGY AS A POTENTIAL TREATMENT FOR DIABETES AND ITS COMPLICATIONS: A REVIEW. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2024; : 103159 doi: 10.1016/j.dsx.2024.103159
|
26 |
Ehsan Arabzadeh, Zahra Samadian, Asghar Tofighi, Javad Tolouei Azar. Alteration of follistatin-like 1, neuron-derived neurotrophic factor, and vascular endothelial growth factor in diabetic cardiac muscle after moderate-intensity aerobic exercise with insulin. Sport Sciences for Health 2020; 16(3): 491 doi: 10.1007/s11332-020-00631-9
|
27 |
Brian Onken, Natallia Kalinava, Monica Driscoll, Kaveh Ashrafi. Gluconeogenesis and PEPCK are critical components of healthy aging and dietary restriction life extension. PLOS Genetics 2020; 16(8): e1008982 doi: 10.1371/journal.pgen.1008982
|
28 |
ZHONGWEI LIU, HUI CAI, YONGHUI DANG, CHUAN QIU, JUNKUI WANG. Adenosine triphosphate-sensitive potassium channels and cardiomyopathies (Review). Molecular Medicine Reports 2016; 13(2): 1447 doi: 10.3892/mmr.2015.4714
|
29 |
Francesco Paneni, Francesco Cosentino. Diabetes and Cardiovascular Disease. 2015; : 49 doi: 10.1007/978-3-319-17762-5_5
|
30 |
Jia Song, Qian Liu, Han Tang, Aibin Tao, Hao Wang, Raymond Kao, Tao Rui. Activation of PI3Kγ/Akt pathway increases cardiomyocyte HMGB1 expression in diabetic environment. Oncotarget 2016; 7(49): 80803 doi: 10.18632/oncotarget.13096
|
31 |
Isabel Álvarez, Luis Hernández, Héctor García, Vicente Villamandos, María Gracia López, Jorge Palazuelos Molinero, Diego Martín Raymondi. High-sensitivity Troponin T Assay in Asymptomatic High Cardiovascular Risk Patients. The TUSARC Registry. Revista Española de Cardiología (English Edition) 2017; 70(4): 261 doi: 10.1016/j.rec.2016.11.018
|
32 |
Lee B. Bockus, Kenneth M. Humphries. cAMP-dependent Protein Kinase (PKA) Signaling Is Impaired in the Diabetic Heart. Journal of Biological Chemistry 2015; 290(49): 29250 doi: 10.1074/jbc.M115.681767
|
33 |
Yang Zhang, Yi-Yuan Zhang, Ting-Ting Li, Jin Wang, Yuan Jiang, Yue Zhao, Xue-Xin Jin, Gen-Long Xue, Ying Yang, Xiao-Fang Zhang, Yang-Yang Sun, Zhi-Ren Zhang, Xu Gao, Zhi-Min Du, Yan-Jie Lu, Bao-Feng Yang, Zhen-Wei Pan. Ablation of interleukin-17 alleviated cardiac interstitial fibrosis and improved cardiac function via inhibiting long non-coding RNA-AK081284 in diabetic mice. Journal of Molecular and Cellular Cardiology 2018; 115: 64 doi: 10.1016/j.yjmcc.2018.01.001
|
34 |
Ortal Nahum-Ankonina, Efrat Kurtzwald-Josefson, Aaron Ciechanover, Maayan Waldman, Orna Shwartz-Rohaker, Edith Hochhauser, Sam J. Meyer, Dan Aravot, Moshe Phillip, Yaron D. Barac. Ubiquitin Proteasome System Role in Diabetes-Induced Cardiomyopathy. International Journal of Molecular Sciences 2023; 24(20): 15376 doi: 10.3390/ijms242015376
|
35 |
Se Chan Kang, Eun-Hwa Sohn, Sung Ryul Lee. Hydrogen Sulfide as a Potential Alternative for the Treatment of Myocardial Fibrosis. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/4105382
|
36 |
Shanshan Hu, Shengying Gu, Chendong Qi, Shuowen Wang, Fengdan Qian, Chenyang Shi, Guorong Fan. Cost‐utility analysis of semaglutide for type 2 diabetes after its addition to the National Medical Insurance System in China. Diabetes, Obesity and Metabolism 2023; 25(2): 387 doi: 10.1111/dom.14881
|
37 |
Peng Duan, Jinxin Wang, Yang Li, Shiqiang Wei, Feng Su, Sanlin Zhang, Yuhui Duan, Lin Wang, Qinglei Zhu. Opening of mitoKATP improves cardiac function and inhibits apoptosis via the AKT-Foxo1 signaling pathway in diabetic cardiomyopathy. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3832
|
38 |
Feixue Zhang, Shan Shan, Chenlu Fu, Shuang Guo, Chao Liu, Shuanglong Wang. Advanced Mass Spectrometry-Based Biomarker Identification for Metabolomics of Diabetes Mellitus and Its Complications. Molecules 2024; 29(11): 2530 doi: 10.3390/molecules29112530
|
39 |
Cecilia Granéli, Ryan Hicks, Gabriella Brolén, Jane Synnergren, Peter Sartipy. Diabetic Cardiomyopathy Modelling Using Induced Pluripotent Stem Cell Derived Cardiomyocytes: Recent Advances and Emerging Models. Stem Cell Reviews and Reports 2019; 15(1): 13 doi: 10.1007/s12015-018-9858-1
|
40 |
Camila Moreno Rosa, Dijon Henrique Salome Campos, David Rafael Abreu Reyes, Felipe Cesar Damatto, Lucas Yamada Kurosaki, Luana Urbano Pagan, Mariana Janini Gomes, Camila Renata Corrêa, Ana Angelica Henrique Fernandes, Marina Politi Okoshi, Katashi Okoshi. Effects of the SGLT2 Inhibition on Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats, a Model of Type 1 Diabetes Mellitus. Antioxidants 2022; 11(5): 982 doi: 10.3390/antiox11050982
|
41 |
Dongjuan Wang, Longfu Jiang, Beili Feng, Nana He, Yue Zhang, Honghua Ye. Protective effects of glucagon‐like peptide‐1 on cardiac remodeling by inhibiting oxidative stress through mammalian target of rapamycin complex 1/p70 ribosomal protein S6 kinase pathway in diabetes mellitus. Journal of Diabetes Investigation 2020; 11(1): 39 doi: 10.1111/jdi.13098
|
42 |
Tao Wu, Yiwei Qu, Shengjie Xu, Yong Wang, Xue Liu, Dufang Ma. SIRT6: A potential therapeutic target for diabetic cardiomyopathy. The FASEB Journal 2023; 37(8) doi: 10.1096/fj.202301012R
|
43 |
Xiao Chang, Kang Lu, Ling Wang, Min Lv, Wenjun Fu. <i>Astraglaus polysaccharide</i> protects diabetic cardiomyopathy by activating NRG1/ErbB pathway. BioScience Trends 2018; 12(2): 149 doi: 10.5582/bst.2018.01027
|
44 |
Saeed Mohammadi, Ahmed Al-Harrasi. Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy?. World Journal of Diabetes 2024; 15(9): 1847-1852 doi: 10.4239/wjd.v15.i9.1847
Abstract(176) |
Core Tip(154) |
Full Article(HTML)(706)
|
Full Article with Cover (PDF)-1354K(32)
|
Full Article (Word)-249K(2)
|
Audio-895K(1)
|
Peer-Review Report-170K(13)
|
Answering Reviewers-54K(23)
|
Full Article (PDF)-986K(52)
|
Full Article (XML)-69K(14)
|
Times Cited (0)
|
Total Visits (1525)
|
Open
|
45 |
Ming Zhang, Ning-Wei Zhu, Wei-Cheng Ma, Meng-Jia Chen, Lei Zheng. Combined treatment with ultrasound-targeted microbubble destruction technique and NM-aFGF-loaded PEG-nanoliposomes protects against diabetic cardiomyopathy-induced oxidative stress by activating the AKT/GSK-3β1/Nrf-2 pathway. Drug Delivery 2020; 27(1): 938 doi: 10.1080/10717544.2020.1785052
|
46 |
Giovanni Antonio Silverii, Loira Toncelli, Lorenzo Casatori, Rachele Bossini, Filippo Nannelli, Laura Pala, Edoardo Mannucci. Assessment of left ventricular global longitudinal strain in patients with type 2 diabetes: Relationship with microvascular damage and glycemic control. Nutrition, Metabolism and Cardiovascular Diseases 2022; 32(4): 994 doi: 10.1016/j.numecd.2022.01.014
|
47 |
Xiangyi Cai, Shuihua Zhang, Dabiao Deng, Honglin Li, Xueqing Guan, Jin Fang, Quan Zhou. Myocardial perfusion at rest in uncomplicated type 2 diabetes patients without coronary artery disease evaluated by 320-multidetector computed tomography. Medicine 2018; 97(5): e9762 doi: 10.1097/MD.0000000000009762
|
48 |
Peter Stiefelhagen. Die „diabetische“ Herzinsuffizienz hat viele Ursachen. Info Diabetologie 2015; 9(6): 48 doi: 10.1007/s15034-015-0766-z
|
49 |
Lamiaa Mohamed Mahmoud, Aya Aly Ashraf Abdel Mageed, Jackline Moawad Saadallah, Mira Farouk Youssef, Liala Ahmed Rashed, Hania Ibrahim Ammar. Interleukin 1β receptor blocker (Anakinra) and regenerative stem cell therapy: two novel approaches effectively ameliorating diabetic cardiomyopathy. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(10): 8023 doi: 10.1007/s00210-024-03152-1
|
50 |
Yue Gao, Zhi-gang Yang, Yan Ren, Xi Liu, Li Jiang, Lin-jun Xie, Bi-yue Hu, Meng-ting Shen, Hua-yan Xu, Zhen-lin Li, Chun-chao Xia, Yu-ming Li, Li-ling Deng, Ming-yan Deng, Xiao-yue Zhou, Ying-kun Guo. Evaluation of myocardial fibrosis in diabetes with cardiac magnetic resonance T1-mapping: Correlation with the high-level hemoglobin A1c. Diabetes Research and Clinical Practice 2019; 150: 72 doi: 10.1016/j.diabres.2019.03.004
|
51 |
Volker H. Schmitt, Anna-Maria Billaudelle, Andreas Schulz, Karsten Keller, Omar Hahad, Sven-Oliver Tröbs, Thomas Koeck, Matthias Michal, Alexander K. Schuster, Gerrit Toenges, Karl J. Lackner, Jürgen H. Prochaska, Thomas Münzel, Philipp S. Wild. Disturbed Glucose Metabolism and Left Ventricular Geometry in the General Population. Journal of Clinical Medicine 2021; 10(17): 3851 doi: 10.3390/jcm10173851
|
52 |
Georgică Târtea, Aurel Popa-Wagner, Veronica Sfredel, Smaranda Ioana Mitran, Alexandra Oltea Dan, Anca-Maria Țucă, Alexandra Nicoleta Preda, Victor Raicea, Eugen Țieranu, Dragoș Cozma, Radu Vătășescu. Chitosan Versus Dapagliflozin in a Diabetic Cardiomyopathy Mouse Model. International Journal of Molecular Sciences 2024; 25(4): 2118 doi: 10.3390/ijms25042118
|
53 |
Chiara Anchisi, Giuliano Marti, Ilaria Bellacosa, David Mary, Giovanni Vacca, Paolo Marino, Elena Grossini. Coronary flow reserve/diastolic function relationship in angina-suffering patients with normal coronary angiography. Journal of Cardiovascular Medicine 2017; 18(5): 325 doi: 10.2459/JCM.0000000000000344
|
54 |
Wenzhen WU, Wen LIU, Degui KONG. Telmisartan alleviates inflammatory response and myocardial apoptosis in diabetic cardiomyopathy rats through TGF-β1/Smad signaling pathway. Minerva Medica 2021; 112(3) doi: 10.23736/S0026-4806.19.06201-3
|
55 |
Kundan Solanki, Sajjan Rajpoot, Evgeny E. Bezsonov, Alexander N. Orekhov, Rohit Saluja, Anita Wary, Cassondra Axen, Kishore Wary, Mirza S. Baig. The expanding roles of neuronal nitric oxide synthase (NOS1). PeerJ 2022; 10: e13651 doi: 10.7717/peerj.13651
|
56 |
B.O. Ajiboye, I.M. Folorunso, K.I. Akinfemiwa, B.E. Oyinloye, O.E. Lawal, O.A. Ojo, M. Ezema, O.R. Ajuwon, E.A. Ardekani. Alkaloid-rich extract of Lannea egregia leaf protect against cardiomyopathy in streptozotocin-induced type 2 diabetic rats. Phytomedicine Plus 2024; 4(1): 100513 doi: 10.1016/j.phyplu.2023.100513
|
57 |
Ewa Radzioch, Bartłomiej Dąbek, Marta Balcerczyk-Lis, Weronika Frąk, Piotr Fularski, Ewelina Młynarska, Jacek Rysz, Beata Franczyk. Diabetic Cardiomyopathy—From Basics through Diagnosis to Treatment. Biomedicines 2024; 12(4): 765 doi: 10.3390/biomedicines12040765
|
58 |
Meng Liu, Hua-Jun Zhang, Han Song, Nan Cheng, Yuan-Bin Wu, Rong Wang. Effect of diabetes mellitus on long-term outcomes of surgical revascularization in patients with ischemic heart failure: a propensity score-matching study. Chinese Medical Journal 2021; 134(10): 1146 doi: 10.1097/CM9.0000000000001421
|
59 |
Young Hee Shin, Jeong Jin Min, Jong-Hwan Lee, Eun-Hee Kim, Go Eun Kim, Myung Hee Kim, Jeong Jin Lee, Hyun Joo Ahn. The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts. Heart and Vessels 2017; 32(5): 618 doi: 10.1007/s00380-016-0936-5
|
60 |
Hannah Smati, Yusuf Kamran Qadeer, Mario Rodriguez, Errol Moras, Gregg C Fonarow, Scott D. Isaacs, Thomas H Marwick, Chayakrit Krittanawong. Diabetic Cardiomyopathy: What Clinicians Should Know. The American Journal of Medicine 2024; doi: 10.1016/j.amjmed.2024.10.026
|
61 |
Jun Ren, James R. Sowers. Application of a Novel Curcumin Analog in the Management of Diabetic Cardiomyopathy. Diabetes 2014; 63(10): 3166 doi: 10.2337/db14-0863
|
62 |
Lin Cong, Yunpeng Bai, Zhigang Guo. The crosstalk among autophagy, apoptosis, and pyroptosis in cardiovascular disease. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.997469
|
63 |
Jason McCourt, Randy Ray Richardson. Atlas of Acquired Cardiovascular Disease Imaging in Children. 2017; : 127 doi: 10.1007/978-3-319-44115-3_24
|
64 |
Emília Mácsai, Ilona Németh, Attila Benke, Gyula Dávid. Effect of diabetes on the relation between troponin T and inflammatory markers in patients on hemodialysis. Orvosi Hetilap 2014; 155(16): 627 doi: 10.1556/OH.2014.29872
|
65 |
Angela R. McGuire, James R. Gill. Diabetic Cardiomyopathy: A Forensic Perspective. Academic Forensic Pathology 2016; 6(2): 191 doi: 10.23907/2016.021
|
66 |
Yu. G. Gorb, V. I. Strona, O. V. Tkachenko, S. A. Serik, V. V. Ryabukha. Features of Pathogenesis and Course of Type 2 Diabetes Mellitus and Comorbid with it Cardiovascular Pathology in Elderly Patients. Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 2021; 6(3): 22 doi: 10.26693/jmbs06.03.022
|
67 |
Patryk Graczyk, Aleksandra Dach, Kamil Dyrka, Andrzej Pawlik. Pathophysiology and Advances in the Therapy of Cardiomyopathy in Patients with Diabetes Mellitus. International Journal of Molecular Sciences 2024; 25(9): 5027 doi: 10.3390/ijms25095027
|
68 |
Hemant V. Kamble, Subhash L. Bodhankar. Cardioprotective effect of concomitant administration of trigonelline and sitagliptin on cardiac biomarkers, lipid levels, electrocardiographic and heamodynamic modulation on cardiomyopathy in diabetic Wistar rats. Biomedicine & Aging Pathology 2014; 4(4): 335 doi: 10.1016/j.biomag.2014.07.009
|
69 |
Assi Milwidsky, Elad Maor, Shaye Kivity, Anat Berkovitch, Sagit Ben Zekry, Alexander Tenenbaum, Enrique Z. Fisman, Aharon Erez, Shlomo Segev, Yechezkel Sidi, Ilan Goldenberg, Rafael Kuperstein. Impaired fasting glucose and left ventricular diastolic dysfunction in middle-age adults: a retrospective cross-sectional analysis of 2971 subjects. Cardiovascular Diabetology 2015; 14(1) doi: 10.1186/s12933-015-0282-4
|
70 |
Hareld Kemps, Nicolle Kränkel, Marcus Dörr, Trine Moholdt, Matthias Wilhelm, Francesco Paneni, Luis Serratosa, Erik Ekker Solberg, Dominique Hansen, Martin Halle, Marco Guazzi. Exercise training for patients with type 2 diabetes and cardiovascular disease: What to pursue and how to do it. A Position Paper of the European Association of Preventive Cardiology (EAPC). European Journal of Preventive Cardiology 2019; 26(7): 709 doi: 10.1177/2047487318820420
|
71 |
|
72 |
Boniface Amanee Elias Lumori, Edwin Nuwagira, Fardous Charles Abeya, Abdirahman Ali Araye, Godfrey Masette, Charles K. Mondo, Samson Okello, Conrad Muzoora, Anthony Muyingo. Association of body mass index with left ventricular diastolic dysfunction among ambulatory individuals with diabetes mellitus in rural Uganda: a cross-sectional study. BMC Cardiovascular Disorders 2022; 22(1) doi: 10.1186/s12872-022-02718-2
|
73 |
Phiwayinkosi V. Dludla, Bongani B. Nkambule, Stephanie C. Dias, Rabia Johnson. Cardioprotective potential of N-acetyl cysteine against hyperglycaemia-induced oxidative damage: a protocol for a systematic review. Systematic Reviews 2017; 6(1) doi: 10.1186/s13643-017-0493-8
|
74 |
Slavica Mutavdzin, Kristina Gopcevic, Sanja Stankovic, Jovana Jakovljevic Uzelac, Milica Labudovic Borovic, Dragan Djuric. The effect of folic acid administration on cardiac tissue matrix metalloproteinase activity and hepatorenal biomarkers in diabetic rats. Canadian Journal of Physiology and Pharmacology 2019; 97(9): 893 doi: 10.1139/cjpp-2019-0027
|
75 |
Yongxia Cheng, Wei Zhao, Xiaodong Zhang, Lixin Sun, Heran Yang, Ying Wang, Yong Cao, Yanhui Chu, Guibo Liu. Downregulation of microRNA‑1 attenuates glucose‑induced apoptosis by regulating the liver X receptor α in cardiomyocytes. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6388
|
76 |
Prasarn Manitpisitkul, Christopher R. Curtin, Kevin Shalayda, Shean‐Sheng Wang, Lisa Ford, Donald Heald. Pharmacokinetic interactions between topiramate and diltiazem, hydrochlorothiazide, or propranolol. Clinical Pharmacology in Drug Development 2014; 3(5): 378 doi: 10.1002/cpdd.107
|
77 |
Emily J. Johnson, Brad P. Dieter, Susan A. Marsh. Evidence for distinct effects of exercise in different cardiac hypertrophic disorders. Life Sciences 2015; 123: 100 doi: 10.1016/j.lfs.2015.01.007
|
78 |
Benjamin Steinhorn, Juliano L. Sartoretto, Andrea Sorrentino, Natalia Romero, Hermann Kalwa, E. Dale Abel, Thomas Michel. Insulin-dependent metabolic and inotropic responses in the heart are modulated by hydrogen peroxide from NADPH-oxidase isoforms NOX2 and NOX4. Free Radical Biology and Medicine 2017; 113: 16 doi: 10.1016/j.freeradbiomed.2017.09.006
|
79 |
Yuki Ikeda, Takayuki Inomata, Teppei Fujita, Yuichiro Iida, Toyoji Kaida, Takeru Nabeta, Shunsuke Ishii, Emi Maekawa, Tomoyoshi Yanagisawa, Tomohiro Mizutani, Takashi Naruke, Toshimi Koitabashi, Ichiro Takeuchi, Junya Ako. Higher hemoglobin A1c levels are associated with impaired left ventricular diastolic function and higher incidence of adverse cardiac events in patients with nonischemic dilated cardiomyopathy. Heart and Vessels 2017; 32(4): 446 doi: 10.1007/s00380-016-0895-x
|
80 |
Anne Ringle, Anne Dornhorst, Michaela B Rehman, Cristina Ruisanchez, Petros Nihoyannopoulos. Evolution of subclinical myocardial dysfunction detected by two-dimensional and three-dimensional speckle tracking in asymptomatic type 1 diabetic patients: a long‑term follow-up study. Echo Research and Practice 2017; 4(4): 73 doi: 10.1530/ERP-17-0052
|
81 |
V.G. Maidannyk, Y.M. Kryvonos, I.O. Mityriaeva-Korniiko, G.V. Gnyloskurenko, S.Y. Romanenko, G.V. Saltyikova, R.V. Terletskyi. CORRELATIONS OF CARDIOVASCULAR INDICATORS IN INSULIN-DEPENDENT DIABETES IN CHILDREN. Eastern Ukrainian Medical Journal 2020; 8(4): 448 doi: 10.21272/eumj.2020;8(4):448-457
|
82 |
Jozaa Z. ALTamimi, Mona N. BinMowyna, Nora A. AlFaris, Reham I. Alagal, Attalla F. El-kott, Ammar M. AL-Farga. Fisetin protects against streptozotocin-induced diabetic cardiomyopathy in rats by suppressing fatty acid oxidation and inhibiting protein kinase R. Saudi Pharmaceutical Journal 2021; 29(1): 27 doi: 10.1016/j.jsps.2020.12.003
|
83 |
Sanket Seksaria, Sidharth Mehan, Bhaskar J. Dutta, Ghanshyam D. Gupta, Subrahmanya S. Ganti, Amrita Singh. Oxymatrine and insulin resistance: Focusing on mechanistic intricacies involve in diabetes associated cardiomyopathy via SIRT1/AMPK and TGF‐β signaling pathway. Journal of Biochemical and Molecular Toxicology 2023; 37(5) doi: 10.1002/jbt.23330
|
84 |
Georgiana-Emmanuela Gilca, Gabriela Stefanescu, Oana Badulescu, Daniela-Maria Tanase, Iris Bararu, Manuela Ciocoiu. Diabetic Cardiomyopathy: Current Approach and Potential Diagnostic and Therapeutic Targets. Journal of Diabetes Research 2017; 2017: 1 doi: 10.1155/2017/1310265
|
85 |
Himangi Vig, Ravinandan AP, Hunsur Nagendra Vishwas, Sachin Tyagi, Shruti Rathore, Ankita Wal, Pranay Wal. An Insight into the Pathogenesis of Diabetic Cardiomyopathy Along with
the Novel Potential Therapeutic Approaches. Current Diabetes Reviews 2024; 20(1) doi: 10.2174/1573399819666230502110511
|
86 |
Yongning Shang, Xiaochun Zhang, Liu Chen, Weiling Leng, Xiaotian Lei, Qi Yang, Ziwen Liang, Jian Wang. Assessment of Left Ventricular Structural Remodelling in Patients with Diabetic Cardiomyopathy by Cardiovascular Magnetic Resonance. Journal of Diabetes Research 2016; 2016: 1 doi: 10.1155/2016/4786925
|
87 |
Gilman D. Plitt, Jordan T. Spring, Michael J. Moulton, Devendra K. Agrawal. Mechanisms, diagnosis, and treatment of heart failure with preserved ejection fraction and diastolic dysfunction. Expert Review of Cardiovascular Therapy 2018; 16(8): 579 doi: 10.1080/14779072.2018.1497485
|
88 |
Amir M. Al Hroob, Mohammad H. Abukhalil, Omnia E. Hussein, Ayman M. Mahmoud. Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate. Biomedicine & Pharmacotherapy 2019; 109: 2155 doi: 10.1016/j.biopha.2018.11.086
|
89 |
Subashini Vijayan, Ganesamoorthy K, Usha Padmini, Ravikumar T. Cardiac Autonomic Neuropathy- An ECG Correlation in Type 2 Diabetes. Journal of Evolution of Medical and Dental Sciences 2019; 8(35): 2733 doi: 10.14260/jemds/2019/593
|
90 |
Bryelle E.O. Alves, Allan K.N. de Alencar, Luis E.R. Gamba, Margarete M. Trachez, Jaqueline S. da Silva, Josenildo S.C. Araújo, Tadeu L. Montagnoli, Luiza V.P. Mendes, Pedro M. Pimentel-Coelho, Valéria do M.N. Cunha, Rosalia Mendez-Otero, Gláucia M.M. Oliveira, Lídia M. Lima, Eliezer J. Barreiro, Roberto T. Sudo, Gisele Zapata-Sudo. Reduction of cardiac and renal dysfunction by new inhibitor of DPP4 in diabetic rats. Pharmacological Reports 2019; 71(6): 1190 doi: 10.1016/j.pharep.2019.07.005
|
91 |
NARENDRA VERA-NUÑEZ, AINHOA R.Y. GUIRAO, JOSÉ DAYVID F. DA SILVA, ISALIRA P. RAMOS, MARÍLIA K.S. TORRES, LUANA CASSANDRA B.B. COELHO, THIAGO HENRIQUE NAPOLEÃO, PATRÍCIA MARIA G. PAIVA, EMILIANO MEDEI. Water-soluble lectin (WSMoL) from Moringa oleifera seeds treatment recovers glycemic levels and improves left ventricular ejection fraction on Type-2 Diabetes mice model. Anais da Academia Brasileira de Ciências 2021; 93(3) doi: 10.1590/0001-3765202120201596
|
92 |
Jing Pan, Rakeshwar Guleria, Sen Zhu, Kenneth Baker. Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling. Journal of Clinical Medicine 2014; 3(2): 566 doi: 10.3390/jcm3020566
|
93 |
Zhanwei Fan, Jianjiang Dong, Yindong Mu, Xian Liu. Nesfatin-1 protects against diabetic cardiomyopathy in the streptozotocin-induced diabetic mouse model via the p38-MAPK pathway. Bioengineered 2022; 13(6): 14670 doi: 10.1080/21655979.2022.2066748
|
94 |
Jake Rajbhandari, Cornelius James Fernandez, Mayuri Agarwal, Beverly Xin Yi Yeap, Joseph M Pappachan. Diabetic heart disease: A clinical update. World Journal of Diabetes 2021; 12(4): 383-406 doi: 10.4239/wjd.v12.i4.383
|
95 |
Rahul Chaudhary, Richa Singh, Rajeev Verma, Prashant Kumar, Nitin Kumar, Lubhan Singh, Sadish Kumar S. Investigation on protective effect of Terminalia bellirica (Roxb.) against drugs induced cardiotoxicity in wistar albino rats. Journal of Ethnopharmacology 2020; 261: 113080 doi: 10.1016/j.jep.2020.113080
|
96 |
Kimberley M. Mellor, Margaret A. Brimble, Lea M.D. Delbridge. Glucose as an agent of post-translational modification in diabetes — New cardiac epigenetic insights. Life Sciences 2015; 129: 48 doi: 10.1016/j.lfs.2014.03.020
|
97 |
K. M. Hassan Ayman, A. Abdallah Mahmoud, A. Abdel-Mageed Eman, Sayed Marwa, M. Soliman Mona, T. Kishk Yehia. Correlation between left ventricular diastolic dysfunction and dyslipidaemia in asymptomatic patients with new-onset type 2 diabetes mellitus. The Egyptian Journal of Internal Medicine 2021; 33(1) doi: 10.1186/s43162-021-00037-0
|
98 |
Shahzad Khan, Syed S. Ahmad, Mohammad A. Kamal. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell. Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21(2): 268 doi: 10.2174/1871530320666200731174724
|
99 |
Elena-Daniela Grigorescu, Cristina-Mihaela Lacatusu, Mariana Floria, Bogdan-Mircea Mihai, Ioana Cretu, Laurentiu Sorodoc. Left Ventricular Diastolic Dysfunction in Type 2 Diabetes—Progress and Perspectives. Diagnostics 2019; 9(3): 121 doi: 10.3390/diagnostics9030121
|
100 |
Jeong Jin Min, Byung-Seop Shin, Jong-Hwan Lee, Yunseok Jeon, Dae Kyun Ryu, Sojin Kim, Young Hee Shin. Effects of Pravastatin on Type 1 Diabetic Rat Heart with or without Blood Glycemic Control. Journal of Diabetes Research 2018; 2018: 1 doi: 10.1155/2018/1067853
|
101 |
Jichun Yang, Long Jiang Zhang, Fan Wang, Tianpei Hong, Zhaofei Liu. Molecular imaging of diabetes and diabetic complications: Beyond pancreatic β-cell targeting. Advanced Drug Delivery Reviews 2019; 139: 32 doi: 10.1016/j.addr.2018.11.007
|
102 |
Yang Liu, Yan-Bo Zhao, Si-Wang Wang, Yu Zhou, Zhi-Shu Tang, Feng Li. Mulberry granules protect against diabetic cardiomyopathy through the AMPK/Nrf2 pathway. International Journal of Molecular Medicine 2017; 40(3): 913 doi: 10.3892/ijmm.2017.3050
|
103 |
H. Ya. Loi, O. М. Oleshchuk, M. M. Korda. ВПЛИВ МЕТФОРМІНУ НА ЕКСПРЕСІЮ α- ТА β-MHC ГЕНІВ ПІСЛЯ ІНФАРКТУ МІОКАРДА У МИШЕЙ. Вісник наукових досліджень 2019; (2): 90 doi: 10.11603/2415-8798.2019.2.10026
|
104 |
Xudong Zhao, Shengwang Liu, Xiao Wang, Yibing Chen, Pai Pang, Qianjing Yang, Jingyi Lin, Shuaishuai Deng, Shentao Wu, Guanwei Fan, Bin Wang. Diabetic cardiomyopathy: Clinical phenotype and practice. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1032268
|
105 |
Qian Wang, Ziying Zhang, Qian Chai, Yongyan Shan, Dexue Lu, Yangwen Chen, Meili Liu, Weihua Wu. Correlation Between Retinopathy and Coronary Microcirculation Dysfunction in Patients with Type 2 Diabetes Mellitus. European Journal of Ophthalmology 2022; 32(5): 2857 doi: 10.1177/11206721221074201
|
106 |
Pujika Emani Munasinghe, Federica Riu, Parul Dixit, Midori Edamatsu, Pankaj Saxena, Nathan S.J. Hamer, Ivor F. Galvin, Richard W. Bunton, Sharon Lequeux, Greg Jones, Regis R. Lamberts, Costanza Emanueli, Paolo Madeddu, Rajesh Katare. Type-2 diabetes increases autophagy in the human heart through promotion of Beclin-1 mediated pathway. International Journal of Cardiology 2016; 202: 13 doi: 10.1016/j.ijcard.2015.08.111
|
107 |
James Ampadu, John E. Morley. Heart failure and cognitive dysfunction. International Journal of Cardiology 2015; 178: 12 doi: 10.1016/j.ijcard.2014.10.087
|
108 |
Alice P. Sowton, Julian L. Griffin, Andrew J. Murray. Metabolic Profiling of the Diabetic Heart: Toward a Richer Picture. Frontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.00639
|
109 |
Min Seok Oh, Ji-hyun Ahn, Wang Soo Lee. Echocardiographic Diagnosis of Diabetic Cardiomyopathy. Clinical Ultrasound 2020; 5(1): 17 doi: 10.18525/cu.2020.5.1.17
|
110 |
Mst Muslima Khatun, Md. Shimul Bhuia, Raihan Chowdhury, Salehin Sheikh, Afiya Ajmee, Faysal Mollah, Md. Sakib Al Hasan, Henrique D.M. Coutinho, Muhammad Torequl Islam. Potential utilization of ferulic acid and its derivatives in the management of metabolic diseases and disorders: An insight into mechanisms. Cellular Signalling 2024; 121: 111291 doi: 10.1016/j.cellsig.2024.111291
|
111 |
Xi Chen, Long Ren, Xing Liu, Xi Sun, Chaorun Dong, Yanan Jiang, Ying Qin, Huan Qu, Jinfeng Jiao, Shuo Wang, Yunlong Bai, Baofeng Yang. Ranolazine protects against diabetic cardiomyopathy by activating the NOTCH1/NRG1 pathway. Life Sciences 2020; 261: 118306 doi: 10.1016/j.lfs.2020.118306
|
112 |
Yuqin Ji, Didi Zhu, Shuchao Qin, Yuanqi Yang. Astragalus polysaccharide liposome nanoparticles mediate fatty acid translocase (FAT)/CD36 to improve fatty acid metabolism and regulate glucocorticoid receptor levels in diabetic cardiomyopathy. Materials Express 2023; 13(11): 1848 doi: 10.1166/mex.2023.2553
|
113 |
Juan Ignacio Burgos, Malena Morell, Juan Ignacio E. Mariángelo, Martin Vila Petroff. Hyperosmotic stress promotes endoplasmic reticulum stress-dependent apoptosis in adult rat cardiac myocytes. Apoptosis 2019; 24(9-10): 785 doi: 10.1007/s10495-019-01558-4
|
114 |
Ahmed A. M. Abdel-Hamid, Alaa El-Din L. Firgany. Atorvastatin alleviates experimental diabetic cardiomyopathy by suppressing apoptosis and oxidative stress. Journal of Molecular Histology 2015; 46(4-5): 337 doi: 10.1007/s10735-015-9625-4
|
115 |
Zhukovska Anna, Shysh Angela, Bacova Barbara, Radosinska Jana, Benova Tamara, Viczenczova Csilla, Dosenko Victor, Moybenko Oleksiy, Tribulova Narcisa. Heart-protective effect of n-3 PUFA demonstrated in a rat model of diabetic cardiomyopathy. Molecular and Cellular Biochemistry 2014; 389(1-2): 219 doi: 10.1007/s11010-013-1943-9
|
116 |
Jia-hui Tian, Qian Wu, Yong-xiang He, Qi-ying Shen, Mubarak Rekep, Gui-ping Zhang, Jian-dong Luo, Qin Xue, Ying-hua Liu. Zonisamide, an antiepileptic drug, alleviates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress. Acta Pharmacologica Sinica 2021; 42(3): 393 doi: 10.1038/s41401-020-0461-z
|
117 |
Mahsa Soleimani-Dodran, Reza Alipanah-Moghadam, Farhad Jeddi, Mohammad Babaei, Ramin Salimnejad, Elham Bahreini. Effect of hydroalcoholic seed extract of Nigella sativa on hepatic and pancreatic factors of Nrf2 and FGF21 in the regulation of insulin transcription factors of MafA and PDX-1 in streptozotocin-treated diabetic rats. Nutrition & Metabolism 2022; 19(1) doi: 10.1186/s12986-022-00699-9
|
118 |
Afsheen Bashir, Farida Ahmad, Sikandar Ali Khan, Zakia Subhan, Summeira Jabeen Shah, Karishama Ali, Fawad Inayat, Irfan Ullah. Comparing Frequency of Cardiovascular Autonomic Neuropathy in Diabetic Cirrhotic with Non Diabetic Cirrhotic Patients. Pakistan BioMedical Journal 2022; 5(1) doi: 10.54393/pbmj.v5i1.169
|
119 |
H. Hetterich, A. Schafnitzel, F. Bamberg. Bildgebung im Syndromkomplex Diabetes mellitus. Der Radiologe 2015; 55(4): 286 doi: 10.1007/s00117-014-2717-4
|
120 |
TING XIAO, JIAN LUO, ZHIXIONG WU, FANG LI, OU ZENG, JUN YANG. Effects of hydrogen sulfide on myocardial fibrosis and PI3K/AKT1-regulated autophagy in diabetic rats. Molecular Medicine Reports 2016; 13(2): 1765 doi: 10.3892/mmr.2015.4689
|
121 |
Hicham Skali, Amil Shah, Deepak K. Gupta, Susan Cheng, Brian Claggett, Jiankang Liu, Natalie Bello, David Aguilar, Orly Vardeny, Kunihiro Matsushita, Elizabeth Selvin, Scott Solomon. Cardiac Structure and Function Across the Glycemic Spectrum in Elderly Men and Women Free of Prevalent Heart Disease. Circulation: Heart Failure 2015; 8(3): 448 doi: 10.1161/CIRCHEARTFAILURE.114.001990
|
122 |
Lara Testai, Vincenzo Brancaleone, Lorenzo Flori, Rosangela Montanaro, Vincenzo Calderone. Modulation of EndMT by Hydrogen Sulfide in the Prevention of Cardiovascular Fibrosis. Antioxidants 2021; 10(6): 910 doi: 10.3390/antiox10060910
|
123 |
Sidhi Laksono, Grace T. Hosea, Zahra Nurusshofa. Diabetic Cardiomyopathy: Pathophysiology and Novel Therapies. Journal of Brown Hospital Medicine 2022; 1(3) doi: 10.56305/001c.37850
|
124 |
Yang Zhang, Jing-Hao Wang, Yi-Yuan Zhang, Ying-Zhe Wang, Jin Wang, Yue Zhao, Xue-Xin Jin, Gen-Long Xue, Peng-Hui Li, Yi-Lin Sun, Qi-He Huang, Xiao-Tong Song, Zhi-Ren Zhang, Xu Gao, Bao-Feng Yang, Zhi-Min Du, Zhen-Wei Pan. Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFβ1 and miR-29 pathways. Scientific Reports 2016; 6(1) doi: 10.1038/srep23010
|
125 |
Wang-Soo Lee, Jaetaek Kim. Application of Animal Models in Diabetic Cardiomyopathy. Diabetes & Metabolism Journal 2021; 45(2): 129 doi: 10.4093/dmj.2020.0285
|
126 |
Jing Wei, Tao Yan, Yuanhong Liang. Targeting TRAF3IP2 alleviates high glucose‐induced cardiomyocyte inflammation and apoptosis. Drug Development Research 2022; 83(1): 167 doi: 10.1002/ddr.21856
|